Exanthema: all 68 studies
Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Wucao Anfu Formula as Adjunctive Treatment for Immune Checkpoint Inhibitor-Related RashNot yet recruitingNCT07821424Not applicable
- Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot StudyEnrolling by invitationNCT07476807Not applicable
- Rash & Diarrhea Prophylaxis With CapivasertibRecruitingNCT07426822Phase 2
- Prospective Clinical Registry for Evaluation of Exanthematous Infections and CoinfectionsNot yet recruitingNCT07112846
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)RecruitingNCT07021495
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT06979453Phase 3
- A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityRecruitingNCT06830863Phase 1/2
- Effect of Bathing on Physiological Parameters, Skin, Bilirubin and Comfort Levels in Infants Receiving PhototherapyRecruitingNCT06819150Not applicable
- TAR-0520 Gel in EGFR Inhibitor-induced FolliculitisRecruitingNCT06818058Phase 2
- Cardamom and Topical Roseomonas in Atopic DermatitisRecruitingNCT06096857Phase 2
- The Relationship Between Body Mass Index, Dental Eruption and Dental Caries Prevalence in School ChildrenRecruitingNCT05902611
- A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast CancerTerminatedNCT05966584Phase 2Results posted
- Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis ComplexTerminatedNCT03363763Phase 2Results posted
- A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular EruptionTerminatedNCT03115567Phase 2Results posted
- Pilot Study: Safety of Chlorhexidine (CHG) Baths in Patients Less Than 2 Months of AgeCompletedNCT02326467Phase 1Results posted
- Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RTCompletedNCT01931150Phase 3Results posted
- Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)CompletedNCT01880515Phase 2Results posted
- 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUXTerminatedNCT01692626Phase 2Results posted
- Safety and Feasibility of Prima-Temp Thermometer PatchCompletedNCT01587014Results posted
- Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).CompletedNCT01242813Phase 2Results posted
- Efficacy and Tolerability of BAF312 in Patients With Polymyositis and DermatomyositisTerminatedNCT01148810Phase 2Results posted
- Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine TherapyCompletedNCT00886795Phase 1/2Results posted
- Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) InhibitorsCompletedNCT00709878Results posted
- Sorafenib-induced Hand- Foot Skin Reaction TreatmentTerminatedNCT00667589Phase 2Results posted
- Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung CancerCompletedNCT00473083Phase 2Results posted
- Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based TherapyCompletedNCT00332163Phase 2Results posted
- Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid ArthritisTerminatedNCT00078806Phase 3Results posted
- Annurca Apple Peel Oleolite for the Treatment of Skin HyperpigmentationCompletedNCT07040345Not applicable
- GI Symptoms in Infants Fed Goat Milk-based Infant FormulaCompletedNCT06755424
- Clinical Study for the Efficacy Evaluation of a Food SupplementCompletedNCT06453837Not applicable
- Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-ToxicitiesActive, not recruitingNCT06399029Phase 2
- The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity ReactionCompletedNCT06012448Phase 4
- Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%CompletedNCT05461456Phase 1
- Evaluation of Parents' Knowledge About Infant TeethingCompletedNCT05374746
- Implementation of a Minor Ailment Service in Community Pharmacy PracticeCompletedNCT05247333Not applicable
- Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer TherapiesStatus unknownNCT04878692Not applicable
- Molecular Mechanisms of Tooth EruptionStatus unknownNCT04675203
- Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor TherapyCompletedNCT04239846Phase 2
- Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.CompletedNCT03992664Not applicable
- Study of Prevalence and Risk Factors of Hypovitaminosis C in Long Term Care UnitCompletedNCT03807791Not applicable
- Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)CompletedNCT03713359Phase 3
- Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal TumorCompletedNCT03440515Phase 2
- Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema?CompletedNCT03102905
- P Gingivalis Oral Infection, Intimamedia Thickening in Infants, AtherosclerosisWithdrawnNCT03083444
- Correlation Between Somatic Growth and Number of Erupted Deciduous TeethStatus unknownNCT03054571
- Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderWithdrawnNCT02677636Phase 3
- Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderWithdrawnNCT02677610Phase 3
- Interceptive Study of Ectopic Eruption of Permanent Maxillary Canine TeethStatus unknownNCT02675036Not applicable
- Randomized Clinical Trial of Occlusal SealantCompletedNCT02589743Phase 2
- Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in EmergencyCompletedNCT02565680Phase 2/3
- Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer PatientsCompletedNCT02239731Phase 2
- Cost-efficacy of Silver Diammine Fluoride in Erupting MolarsStatus unknownNCT01508611Not applicable
- Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human SkinTerminatedNCT01466504
- Pre-emptive Low-dose Doxycycline During Anti-EGFR TreatmentStatus unknownNCT01380262
- National Trends in Otitis Media in Children Under 5 Years of AgeCompletedNCT01339546
- FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular ExanthemaStatus unknownNCT01315990Phase 4
- Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)WithdrawnNCT01299220Phase 4
- HIV Indicator Diseases Survey Across Europe - UK ArmStatus unknownNCT01196468
- Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI)CompletedNCT01136005Phase 3
- Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine HypersensitivityCompletedNCT01044810
- Evaluating for Contact Allergies in Patients With Chronic UrticariaCompletedNCT00868036
- Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced RashWithdrawnNCT00803842Not applicable
- Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated RashCompletedNCT00656786Phase 1
- Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow TransplantationTerminatedNCT00610818
- An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).CompletedNCT00492323Phase 2
- A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related RashTerminatedNCT00343187Phase 2
- Subcutaneous Amifostine Safety StudyCompletedNCT00158041Phase 4
- Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile DermatomyositisCompletedNCT00059748